Chungcheongbuk-do, South Korea

Se Yeon Kim

This inventor holds 1 USPTO granted patent. Top assignee: Aprogen Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Se Yeon Kim. Retrieved from https://idiyas.com/inventor/se-yeon-kim-320epbzy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Se Yeon Kim: Innovator in Anthrax Toxin Neutralization

Introduction

Se Yeon Kim is a prominent inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on creating solutions for serious health threats, including anthrax toxin.

Latest Patents

Se Yeon Kim holds a patent for a monoclonal antibody that is specific to anthrax toxin. This antibody exhibits a very high affinity for the toxin and demonstrates potent toxin-neutralizing activity. The patent also includes a composition for neutralizing anthrax toxin that comprises the antibody, as well as a kit designed for detecting anthrax toxin.

Career Highlights

Kim is associated with Aprogen Inc., a company that specializes in biopharmaceuticals. His work at Aprogen Inc. has allowed him to focus on innovative solutions that address critical health issues. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in medical science.

Collaborations

Some of his notable coworkers include Hyo Jeong Hong and Kyung Soo Inn. Their collaborative efforts in research and development have further enhanced the impact of their work in the field.

Conclusion

Se Yeon Kim's innovative work in developing monoclonal antibodies for anthrax toxin neutralization showcases his commitment to advancing biotechnology. His contributions are vital in the ongoing fight against biological threats.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…